Testing version — LOERadar is in active testing. Features and data may change.
MOTRIN (IBUPROFEN) | LOERadar
MOTRIN
NDA
IBUPROFEN | N020418 | MCNEIL PEDIATRICS
1 strength0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 100MG
0 patents0 exclusivities▴
TABLET;ORAL | Approved: Nov 16, 1994
No patent or exclusivity listings for this strength.